Abstract
This study examines people’s habituation to COVID-19-related information over almost three years. Using publicly available data from 47 Japanese prefectures, we analyse how human mobility responded to COVID-19-related information, such as the number of COVID-19-infected cases and the declaration of a state of emergency (DSE), using an interactive effects model, which is a type of panel data regression. The results show that Japanese citizens were generally fearful and cautious in the first wave of an unknown infection; however, they gradually became habituated to similar infection information during subsequent waves. Nevertheless, the level of habituation decreased in response to different types of infections, such as new variants. By contrast, regarding the DSE, it is more plausible to consider that human mobility responds to varying requests rather than habituate them. We also find spatial spillovers of infection information on human mobility using a spatial weight matrix included in the regression model. The implementation of flexible human mobility control policies by closely monitoring human mobility can prevent excessive or insufficient mobility control requests. Such a flexible policy can efficiently suppress infection spread and prevent economic activity reduction more than necessary. These implications are useful for evidence-based policymaking during future pandemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author gratefully acknowledges financial support from the Japan Society for the Promotion of Science through Grant-in-Aid for Scientific Research (No. 20K13484).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
I only changed the Acknowledgements.
Data Availability
The datasets generated during and/or analysed during the current study are available from the author on reasonable request.
